CRST and Turku PET Centre offer 43 Clinical PET Tracers

Clinical Research Services Turku CRST, specialist in early phases of clinical drug development and Turku PET Centre, one of the leading PET centres in the world have together published a list of over 40 tracers available for clinical research. The tracers are available for clinical research in areas such as CNS, cardiovascular diseases and oncology.

Dr. Mika Scheinin, M.D, Director of CRST and Professor of Pharmacology said “We are happy to publish this list and make our colleagues more aware of the possibilities to use PET imaging as a tool for early ‘go’ or ‘no go’ decisions, for earlier proof of concept, to reduce the risk of late-phase failure. In the long run, this is a cost-efficient technique in clinical drug development”.

He continues “One of our strengths is that we have a wide network of clinical experts representing various therapy areas within the University of Turku and Turku University Hospital. These experts represent a valuable resource when we want to reach different patient populations. Collaboration with Turku PET Centre gives us direct access to the latest scientific PET imaging expertise and technological applications, which further improves our possibilities to help our Pharma customers obtain valuable information about their products”.

A full list of tracers is available at www.crst.fi/proofofconcept

About CRST
CRST is a Clinical Research Organisation that provides a wide array of clinical, preclinical and bio-analytical research services for drug developers. CRST specialises in the early phases of clinical drug development, in particular in the facilitation of proof-of-concept by scientifically demanding studies.

CRST offers a committed team who are professionals in clinical trials. Its team comprises clinical researchers, laboratory technicians, study nurses and other research personnel who will work alongside you to achieve your goals in study planning, reporting and conduct.

The company’s aptitude in technologies and expertise has been built on networking with academic and private partners in Finland. Through networking, CRST has enhanced its knowledge enabling it to provide services covering all areas of clinical drug research. This allows them to provide cutting-edge solutions established on the most up-to-date scientific information.

The work carried out at CRST is in accordance with Good Clinical Practice guidelines as well as the European Medicines Agency (EMA) and Food and Drug Administration (FDA) regulations in regard to clinical studies.

Contact:
CRST
Ville Ranta- Panula, M.SC.
Business Development Manager
Tel:+358 2333 7635
Email: [email protected]

For more information or to discuss the 43 Clinical PET Tracers available please contact us directly.